Detailed information for compound 29238
Basic information
Technical information
- TDR Targets ID: 29238
- Name: 7-methoxy-6-(1,3-oxazol-5-yl)-2-phenyl-1H-qui nolin-4-one
- MW: 318.326 | Formula: C19H14N2O3
-
H donors: 1
H acceptors: 3
LogP: 3.55
Rotable bonds: 3
Rule of 5 violations (Lipinski): 1 - SMILES: COc1cc2nc(cc(c2cc1c1cnco1)O)c1ccccc1
- InChi: 1S/C19H14N2O3/c1-23-18-9-16-13(7-14(18)19-10-20-11-24-19)17(22)8-15(21-16)12-5-3-2-4-6-12/h2-11H,1H3,(H,21,22)
- InChiKey: HHMIBIGHTIBSRR-UHFFFAOYSA-N
Network
Hover on a compound node to display the structore
Synonyms
- 7-methoxy-6-oxazol-5-yl-2-phenyl-1H-quinolin-4-one
- 7-methoxy-6-(5-oxazolyl)-2-phenyl-1H-quinolin-4-one
- 7-methoxy-6-oxazol-5-yl-2-phenyl-4-quinolone
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Homo sapiens | IMP (inosine 5'-monophosphate) dehydrogenase 1 | Starlite/ChEMBL | References |
| Homo sapiens | IMP (inosine 5'-monophosphate) dehydrogenase 2 | Starlite/ChEMBL | References |
Predicted pathogen targets for this compound
By orthology
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model
Ranking Plot
Putative Targets List
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| IC50 (binding) | = 0.008 uM | Inhibition of human inosine monophosphate dehydrogenase IMPDH II | ChEMBL. | 12565968 |
| IC50 (binding) | = 0.008 uM | Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II) | ChEMBL. | 12657262 |
| IC50 (binding) | = 0.008 uM | Inhibition of inosine-5'-monophosphate dehydrogenase 2. | ChEMBL. | 12781195 |
| IC50 (binding) | = 0.008 uM | Inhibition of human inosine monophosphate dehydrogenase IMPDH II | ChEMBL. | 12565968 |
| IC50 (binding) | = 0.008 uM | Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II) | ChEMBL. | 12657262 |
| IC50 (binding) | = 0.008 uM | Inhibition of inosine-5'-monophosphate dehydrogenase 2. | ChEMBL. | 12781195 |
| IC50 (binding) | = 0.099 uM | Inhibitory activity of the compound against inosine monophosphate dehydrogenase IMPDH type I | ChEMBL. | 12565968 |
| IC50 (binding) | = 0.099 uM | Inhibitory activity of the compound against inosine monophosphate dehydrogenase IMPDH type I | ChEMBL. | 12565968 |
| IC50 (functional) | = 0.69 uM | Inhibitory activity of the compound against CEM cell proliferation | ChEMBL. | 12565968 |
| IC50 (functional) | = 0.69 uM | Inhibition of CEM T-cell proliferation | ChEMBL. | 12657262 |
| IC50 (functional) | = 0.69 uM | Inhibition of CEM cell proliferation. | ChEMBL. | 12781195 |
| IC50 (functional) | = 0.69 uM | Inhibitory activity of the compound against CEM cell proliferation | ChEMBL. | 12565968 |
| IC50 (functional) | = 0.69 uM | Inhibition of CEM T-cell proliferation | ChEMBL. | 12657262 |
| IC50 (functional) | = 0.69 uM | Inhibition of CEM cell proliferation. | ChEMBL. | 12781195 |
| Ki (binding) | = 7 nM | Inhibitory activity of the compound against IMPDH II with respect to IMP and NAD | ChEMBL. | 12565968 |
| Ki (binding) | = 7 nM | Inhibitory activity of the compound against IMPDH II with respect to IMP and NAD | ChEMBL. | 12565968 |
| Ratio (binding) | = 12 | Ratio of IC50(Type I) to IC50(Type II) | ChEMBL. | 12565968 |
| Ratio (binding) | = 12 | Ratio of IC50(Type I) to IC50(Type II) | ChEMBL. | 12565968 |
Phenotypes
Whole-cell/tissue/organism interactions
| Species name | Source | Reference | Is orphan |
|---|---|---|---|
| Homo sapiens | ChEMBL23 | 12565968 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL23843
- PubChem: 9883477
Bibliographic References
3 literature references were collected for this gene.
If you have references for this compound, please enter them in a user comment (below) or Contact us.